Port Capital LLC purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel reports. The firm purchased 7,247 shares of the company’s stock, valued at approximately $931,000.
Several other hedge funds and other institutional investors have also made changes to their positions in MKGAF. Vantage Point Financial LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter worth about $364,000. Wallace Capital Management Inc. acquired a new stake in Merck KGaA in the 2nd quarter valued at about $1,520,000. Freestone Grove Partners LP purchased a new position in Merck KGaA during the 2nd quarter valued at about $3,490,000. Caisse de depot et placement du Quebec purchased a new position in Merck KGaA during the 2nd quarter valued at about $571,582,000. Finally, Gallagher Fiduciary Advisors LLC acquired a new position in Merck KGaA during the second quarter worth about $752,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.4%
Shares of OTCMKTS MKGAF opened at $164.58 on Thursday. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a market capitalization of $21.27 billion, a PE ratio of 25.13 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm’s 50-day moving average is $163.19 and its two-hundred day moving average is $148.83.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
